Innovating Works

DRAKHAR STUDIO

Activa
GLORIA: Comparing the effectiveness and safety of additional low dose glucocorticoid in treatment strategies... DRAKHAR STUDIO participó en un H2020: H2020-PHC-2014-2015 GLORIA aims to prove that the addition of chronic low dose glucocorticoids (GC) to current antirheumatic therapy is highly cost-effective an...
2015-04-08 - 2021-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.